The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation - Virakul, S; Dalm, V A; Paridaens, D; van den Bosch, W A; Hirankarn, N; van Hagen, P M; Dik, W A (Graefes Arch Clin Exp Ophthalmol, 2014)